XML 115 R102.htm IDEA: XBRL DOCUMENT v3.22.2
Credit Quality of Financing Receivables and the Allowance for Credit Losses (Information about Allowance for Credit Losses) (Detail) - JPY (¥)
¥ in Millions
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance ¥ 79,995 ¥ 56,836 ¥ 58,011
Provision (Reversal) 0 0 24,425
Charge-offs (24,897) (37,432) (24,920)
Recoveries 474 805 788
Other 3,818 858 (1,468)
Ending balance 71,416 79,995 56,836
Allowance for credit losses, Individually Evaluated for Impairment     13,447
Allowance for credit losses, Not Individually Evaluated for Impairment 49,660 58,141 43,389
Financing receivables, Ending balance 4,744,682 4,609,702 4,694,256
Financing receivables, Individually evaluated for impairment     85,820
Financing receivables, Not individually evaluated for impairment     4,608,436
Consumer borrowers      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance   20,542 21,195
Provision (Reversal)     12,254
Charge-offs     (13,723)
Recoveries     554
Other     262
Ending balance     20,542
Allowance for credit losses, Individually Evaluated for Impairment     3,602
Allowance for credit losses, Not Individually Evaluated for Impairment     16,940
Financing receivables, Ending balance 2,343,030 2,311,624 2,171,139
Financing receivables, Individually evaluated for impairment     26,533
Financing receivables, Not individually evaluated for impairment     2,144,606
Corporate borrowers      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Financing receivables, Ending balance 1,343,679 1,268,560  
Purchased loans      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance 1,835 1,458 3,186
Provision (Reversal)     (24)
Charge-offs (2,372) (4,040) (1,789)
Recoveries 114 46 77
Other 15 119 8 [1]
Ending balance 1,575 1,835 1,458
Allowance for credit losses, Individually Evaluated for Impairment     667
Allowance for credit losses, Not Individually Evaluated for Impairment ¥ 608 681 791
Financing receivables, Ending balance     13,218
Financing receivables, Individually evaluated for impairment     1,605
Financing receivables, Not individually evaluated for impairment     11,613
Non-recourse Loans | Corporate borrowers      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance   1,786 919
Provision (Reversal)     903
Charge-offs     (1)
Recoveries     0
Other     (35)
Ending balance     1,786
Allowance for credit losses, Individually Evaluated for Impairment     228
Allowance for credit losses, Not Individually Evaluated for Impairment     1,558
Financing receivables, Ending balance     132,081
Financing receivables, Individually evaluated for impairment     2,466
Financing receivables, Not individually evaluated for impairment     129,615
Other loans | Corporate borrowers      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance   21,358 20,662
Provision (Reversal)     7,988
Charge-offs     (6,548)
Recoveries     133
Other     (877)
Ending balance     21,358
Allowance for credit losses, Individually Evaluated for Impairment     8,950
Allowance for credit losses, Not Individually Evaluated for Impairment     12,408
Financing receivables, Ending balance     1,296,854
Financing receivables, Individually evaluated for impairment     55,216
Financing receivables, Not individually evaluated for impairment     1,241,638
Direct financing leases      
Financing Receivable, Allowance for Credit Losses [Line Items]      
Beginning balance   ¥ 11,692 12,049
Provision (Reversal)     3,304
Charge-offs     (2,859)
Recoveries     24
Other     (826)
Ending balance     11,692
Allowance for credit losses, Individually Evaluated for Impairment     0
Allowance for credit losses, Not Individually Evaluated for Impairment     11,692
Financing receivables, Ending balance     1,080,964
Financing receivables, Individually evaluated for impairment     0
Financing receivables, Not individually evaluated for impairment     ¥ 1,080,964
[1] Other includes foreign currency translation adjustments.